BIF adds Cadmus Animal Health to its investment portfolio

6 August 2025 Booster Innovation Fund adds Cadmus Animal Health to its investment portfolio Booster is pleased to announce the addition of Cadmus Animal Health to the Booster Innovation Fund (BIF) portfolio. Cadmus Animal Health operates in the animal health part of the life sciences sector. It is developing an immunotherapeutic for the treatment of chronic periodontal disease in companion animals. Cadmus Animal Health was formed in 2021 and is classified as seed stage. BIF will make a cash investment of up to $500,000, with an initial investment of $250,000. Following this initial transaction (and issue of additional units to fund the purchase), Cadmus Animal Health will represent 1.2% of BIF’s investment portfolio which currently has over 35 active companies, and a net asset value of $21.5m. Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of the process described in the fund’s Product Disclosure Statement (PDS) that is available at www.booster.co.nz For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-innovation-fund.aspx For more information, please contact: Gary Scott Company Secretary Booster Investment Management Limited 04 8944300 About Booster Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of the Booster Group which has been helping New Zealanders save since 1998. The group currently administers superannuation and investment funds of over $7 billion on behalf of more than 200,000 New Zealanders. BIF is a managed investment fund that invests in early-stage companies founded on intellectual property originated or developed in New Zealand. For more information, including a copy of the Product Disclosure Statement, please visit www.booster.co.nz